| Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy S Toyoda, W Fukuokaya, K Mori, T Kawada, S Katayama, S Nishimura, ... Japanese Journal of Clinical Oncology, hyae108, 2024 | | 2024 |
| Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer Y Kura, MA De Velasco, K Sakai, H Uemura, K Fujita, K Nishio Human Cell, 1-13, 2024 | | 2024 |
| First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety T Yanagisawa, K Mori, T Kawada, S Katayama, T Uchimoto, T Tsujino, ... Urologic Oncology: Seminars and Original Investigations, 2024 | | 2024 |
| Initial experience with robot-assisted adrenalectomy for giant adrenal tumors T Ohzeki, H Kita, R Kunishige, T Hayashi, T Nishioka, K Sugimoto, ... Asian Journal of Urology 11 (3), 507, 2024 | | 2024 |
| Gleason Pattern 5 May Be a Prognostic Factor in Radium-223 Treatment M Nishimoto, K Fujita, A Ri, S Fujimoto, Y Oguma, S Toyoda, ... Cancer Diagnosis & Prognosis 4 (4), 441, 2024 | | 2024 |
| Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Y Yamamoto, M Nishimoto, Y Akashi, K Kiba, T Minami, M Nozawa, ... Anticancer Research 44 (7), 3155-3161, 2024 | | 2024 |
| Association of lung immune prognostic index with survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab S Yamashita, S Hamamoto, J Furukawa, K Fujita, M Takahashi, M Miyake, ... Japanese Journal of Clinical Oncology 54 (6), 722-729, 2024 | | 2024 |
| Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma S Yamashita, S Hamamoto, J Furukawa, K Fujita, M Takahashi, M Miyake, ... Scientific Reports 14 (1), 12398, 2024 | | 2024 |
| C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma T Uchimoto, T Matsuda, K Komura, W Fukuokaya, T Adachi, Y Hirasawa, ... Targeted Oncology, 1-10, 2024 | 1 | 2024 |
| Abstract A002: Assessment of the diagnostic accuracy of Oncuria-Detect® for detection of upper tract urothelial carcinoma T Sakatani, S Tanaka, K Fujita, J Linehan, K Murakami, R Lee, I Pagano, ... Clinical Cancer Research 30 (10_Supplement), A002-A002, 2024 | | 2024 |
| J‐AVENUE: a retrospective, real‐world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first‐line … E Kikuchi, N Hayakawa, M Nakayama, M Uno, H Nakatsu, C Kitagawa, ... International Journal of Urology, 2024 | 1 | 2024 |
| MP05-19 POLYGENETIC RISK SCORE FOR PROSTATE CANCER IS ASSOCIATED WITH LIPOPOLYSACCHARIDE PATHWAY IN GUT MICROBIOME K Hatano, Y Tomofuji, M Matsushita, T Oka, D Motooka, S Fujimoto, ... Journal of Urology 211 (5S), e50, 2024 | | 2024 |
| MP15-04 EIF2S1 IN URINARY EXTRACELLULAR VESICLES AS A NOVEL DIAGNOSTIC MARKER FOR BLADDER CANCER E Tomiyama, K Fujita, T Kato, K Hatano, A Kawashima, N Nonomura The Journal of Urology 211 (5S), e230, 2024 | | 2024 |
| PD20-07 ONCOLOGIC OUTCOMES IN PATIENTS WITH VARIANT HISTOLOGIES OF UPPER TRACT UROTHELIAL CANCER: RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT M Pallauf, SA Fletcher, M Rezaee, M Rouprêt, SA Boorjian, AM Potretzke, ... The Journal of Urology 211 (5S), e449, 2024 | | 2024 |
| PD35-03 GENOME-WIDE CRISPR SCREENS IDENTIFIED THAT DCLRE1C REGULATES THE RADIOSENSITIVITY OF PROSTATE CANCER T Oka, K Hatano, K Nimura, Y Ishizuya, Y Horibe, A Yoshimura, M Tani, ... Journal of Urology 211 (5S), e725, 2024 | | 2024 |
| MP59-02 IMIDAZOLINE 2 RECEPTOR ACTIVATION IMPROVES DETRUSOR OVERACTIVITY OF MICE WITH SPINAL CORD INJURY THROUGH RELAXATION OF BLADDER SMOOTH MUSCLES M Hashimoto, K Matsuoka, KJ Cho, SL Daugherty, N Shimizu, K Fujita, ... Journal of Urology 211 (5S), e957, 2024 | | 2024 |
| PD41-07 ASSESSMENT OF THE DIAGNOSTIC ACCURACY OF ONCURIA-DETECT® FOR DETECTION OF UPPER TRACT UROTHELIAL CARCINOMA T Sakatani, K Fujita, J Linehan, K Murakami, R Lee, I Pagano, C Rosser, ... Journal of Urology 211 (5S), e888, 2024 | | 2024 |
| Durable response to enfortumab vedotin compared to re-challenging chemotherapy in metastatic urothelial carcinoma after checkpoint inhibitors T Uchimoto, S Tsuchida, K Komura, W Fukuokaya, T Adachi, Y Hirasawa, ... Targeted Oncology 19 (3), 401-410, 2024 | 1 | 2024 |
| Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti … A Nagahara, M Uemura, M Sato, W Nakata, M Tsujihata, T Takao, ... Japanese Journal of Clinical Oncology 54 (5), 584-591, 2024 | | 2024 |
| Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second‐line treatment with tyrosine kinase inhibitor following first‐line immune‐oncology … Y Matsushita, T Kojima, T Osawa, T Sazuka, S Hatakeyama, K Goto, ... International Journal of Urology 31 (5), 526-533, 2024 | 3 | 2024 |
